Soluble transferrin receptor for the evaluation of erythropoiesis and iron status (Q35067710)

6 August 2017

1 reference

title

Soluble transferrin receptor for the evaluation of erythropoiesis and iron status (English)

1 reference

6 August 2017

Yves Beguin

1

1 reference

6 August 2017

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

329

1 reference

6 August 2017

issue

1-2

1 reference

6 August 2017

page(s)

9-22

1 reference

The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Circulating transferrin receptor in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Transferrin receptors in rat plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Body iron stores decrease in boys during pubertal development: the transferrin receptor-ferritin ratio as an indicator of iron status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum erythropoietin in chronic lymphocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum erythropoietin and serum transferrin receptor levels in aplastic anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Assessment of erythropoiesis following renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

The clinical significance of serum transferrin receptor levels in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Evaluation of serum soluble transferrin receptors and erythropoietin levels as indicators for erythropoietic activity among multi-transfused beta-thalassemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum transferrin receptor as a marker of erythropoiesis suppression in patients on chronic transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: a multicenter randomized controlled study. Multicenter Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Circulating transferrin receptor during erythropoietin medication of anemic patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Erythropoietin abuse in athletes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Effect of recombinant human erythropoietin in preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

EPO, red cells, and serum transferrin receptor in continuous and intermittent hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

"Living high-training low" altitude training improves sea level performance in male and female elite runners

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

A second molybdoprotein aldehyde dehydrogenase from Amycolatopsis methanolica NCIB 11946.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum transferrin receptor in hereditary hemochromatosis and African siderosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Evaluation of kits for measurement of the soluble transferrin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Diagnostic utility of serum transferrin receptors measurement in assessing iron status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Usefulness of serum transferrin receptor and serum ferritin in diagnosis of iron deficiency in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

The Advia 120 red blood cells and reticulocyte indices are useful in diagnosis of iron-deficiency anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Reticulocyte subpopulations and reticulocyte maturity index (RMI) rise as body iron status falls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Intake and indicators of iron and zinc status in children consuming diets low in saturated fat and cholesterol: the STRIP baby study. Special Turku Coronary Risk Factor Intervention Project for Babies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

The ratio of serum transferrin receptor and serum ferritin in the diagnosis of iron status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Transferrin receptor-ferritin index: a useful parameter in differential diagnosis of iron deficiency and hyperplastic erythropoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Reticulocyte hemoglobin content to diagnose iron deficiency in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Response of serum transferrin receptor to iron supplementation in iron-depleted, nonanemic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Acute functional iron deficiency in obese subjects during a very-low-energy all-protein diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Prevalence of iron deficiency with and without concurrent anemia in population groups with high prevalences of malaria and other infections: a study in Côte d'Ivoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Day-to-day variation in iron status indexes is similar for most measures in elderly women with and without rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Assessment of iron status using plasma transferrin receptor in pregnant women with and without human immunodeficiency virus infection in Malawi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Newborns have unique confounding factors regarding the TfR-F ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Is serum transferrin receptor useful for detecting iron-deficiency in anaemic patients with chronic inflammatory diseases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum transferrin receptors in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum transferrin receptor levels in anaemic patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum transferrin receptor in children and adolescents with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Prediction of iron deficiency in chronic inflammatory rheumatic disease anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum transferrin receptor levels in anaemia of rheumatoid arthritis and effects of iron chelation treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

A soluble form of the human transferrin receptor is released by activated lymphocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Assessment of iron status in cystic fibrosis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

The usefulness of serum transferrin receptor and ferritin for assessing anemia in rheumatoid arthritis: comparison with bone marrow iron study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Iron deficiency anaemia in hospitalised patients: value of various laboratory parameters. Differentiation between IDA and ACD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Ferritin and serum transferrin receptor predict iron deficiency in anemic patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Iron deficiency and anemia of chronic disease in elderly women: a discriminant-analysis approach for differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum transferrin receptor for assessment of iron status in healthy prepubertal and early pubertal boys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Soluble transferrin receptor in the study of fetal erythropoietic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Plasma transferrin receptor levels and indices of erythropoiesis and iron status in healthy term infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum soluble transferrin receptor and the prediction of marrow aspirate iron results in a heterogeneous group of patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum soluble transferrin receptor in the diagnosis of iron deficiency in chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Reduced soluble transferrin receptor concentrations in acute malaria in Vanuatu.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Impact of acute malaria on plasma concentrations of transferrin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Malaria, hookworms and recent fever are related to anemia and iron status indicators in 0- to 5-y old Zanzibari children and these relationships change with age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Lack of difference in iron status assessed by soluble transferrin receptor between children with cerebral malaria and those with non-cerebral malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum transferrin receptor: a specific marker of iron deficiency in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

The impact of malarial infection and diet on the anaemia status of rural pregnant Malawian women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Change in erythropoiesis with gestational age during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Assessment of iron status of Zairean women of childbearing age by serum transferrin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum transferrin receptors in detection of iron deficiency in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Iron status in pregnant women: which measurements are valid?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Serum transferrin receptor measurements in hematologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Soluble and cell-associated transferrin receptor in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900005-6

10.1016/S0009-8981(03)00005-6

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference